Profile: Dynavax Technologies Corporation develops therapeutic products to treat and prevent infection diseases, allergies & cancer. Our clinical programs include HEPLISAV™ hepatitis B vaccine, TOLAMBA™ for Ragweed Allergy and Hepatitis B Therapy. Our HBV therapeutic candidate combines surface and core antigen of HBV & is designed to induce a potent immune response against virus-infected cells in the liver.
6 Products/Services (Click for related suppliers)
| |||||
• | Cancer Therapy | • | Cat Allergy Immunotherapy | • | Flu Vaccines |
• | Hepatitis B Therapy | • | Hepatitis C Therapy | • | Peanut Allergy Immunotherapy |